Headlines From Washington
ASH’s advocacy is forging ahead following the start of the 119th Congress in January of this year. Led by members of ASH’s Committees on Government Affairs and Practice, advocates have worked to overcome significant obstacles, including delayed funding for research and public health programs and executive actions that have adversely affected research and patient care. Read More
Latest Articles

President's Column
Stand Up and Be Counted
April 14, 2025
"Let’s all be that person who’s going to stand up and fight for science, fight for research, fight for hematology, and fight for our patients. If not us, then who?”
Featured Content

Truly COSMIC: An ASH Research Collaborative First
The COSMIC study highlights how decentralized research can improve patient engagement and data collection while offering a robust model for future pandemic preparedness and response efforts.

CRISPR-Based Diagnostic Assay for Acute Promyelocytic Leukemia
Improving APL outcomes in developing countries is a multifaceted process including, but not limited to, rapid diagnosis.

Viscoelastic Testing for Perioperative Bleeding Management
VET continues to evolve as a useful, rapid, point-of-care test that is increasingly used for goal-based therapy and patient management of major bleeding in a perioperative setting and critically ill patients.